Fidelity Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Fidelity Investments’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$612K	Buy	2,470 +179	+8%	+$38.6K	﹤0.01%	3207
2026 Q1	$460K	Buy	2,291 +1,159	+102%	+$240K	﹤0.01%	3161
2025 Q4	$234K	Sell	1,132 -11	-1%	-$2.2K	﹤0.01%	3365
2025 Q3	$205K	Buy	1,143 +160	+16%	+$27.2K	﹤0.01%	3333
2025 Q2	$159K	Sell	983 -223	-18%	-$35.5K	﹤0.01%	3408
2025 Q1	$205K	Buy	1,206 +136	+13%	+$23.6K	﹤0.01%	3235
2024 Q4	$178K	Buy	1,070 +77	+8%	+$13.2K	﹤0.01%	3316
2024 Q3	$171K	Sell	993 -35	-3%	-$5.79K	﹤0.01%	3252
2024 Q2	$158K	Buy	1,028 +38	+4%	+$5.7K	﹤0.01%	3116
2024 Q1	$152K	Sell	990 -456	-32%	-$69.5K	﹤0.01%	3122
2023 Q4	$229K	Buy	1,446 +826	+133%	+$119K	﹤0.01%	2927
2023 Q3	$90.7K	Buy	620 +2	+0.3%	+$305	﹤0.01%	3130
2023 Q2	$94.6K	Sell	618 -4	-0.6%	-$624	﹤0.01%	3184
2023 Q1	$96.4K	Sell	622 -42	-6%	-$6.6K	﹤0.01%	3219
2022 Q4	$102K	Sell	664 -282	-30%	-$41.6K	﹤0.01%	3202
2022 Q3	$125K	Sell	946 -191	-17%	-$26.8K	﹤0.01%	3197
2022 Q2	$154K	Buy	1,137 +301	+36%	+$41.5K	﹤0.01%	3200
2022 Q1	$125K	Sell	836 -84	-9%	-$12.4K	﹤0.01%	3383
2021 Q4	$149K	Sell	920 -13	-1%	-$2.1K	﹤0.01%	3007
2021 Q3	$155K	Sell	933 -37	-4%	-$6.32K	﹤0.01%	2994
2021 Q2	$167K	Buy	970 +648	+201%	+$107K	﹤0.01%	2952
2021 Q1	$52K	Buy	322 +95	+42%	+$16.3K	﹤0.01%	3037
2020 Q4	$38K	Buy	227 +39	+21%	+$6.33K	﹤0.01%	3049
2020 Q3	$30K	Sell	188 -66	-26%	-$10.8K	﹤0.01%	2972
2020 Q2	$43K	Sell	254 -39	-13%	-$6.12K	﹤0.01%	2832
2020 Q1	$38K	Buy	293 +18	+7%	+$2.56K	﹤0.01%	2823
2019 Q4	$41K	Buy	275 +85	+45%	+$11.7K	﹤0.01%	2938
2019 Q3	$24K	Sell	190 -6	-3%	-$799	﹤0.01%	3023
2019 Q2	$28K	Buy	196 +26	+15%	+$3.59K	﹤0.01%	2997
2019 Q1	$25K	Buy	170 +169	+16,900%	+$24.3K	﹤0.01%	2922
2018 Q4	$0	Buy	+1	New	+$137	﹤0.01%	3678

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Fidelity Investments's FBT Position: Q2 2026 in Review

Fidelity Investments increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.8% in Q2 2026, buying an estimated $38.6K and bringing the position to 2,470 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Fidelity Investments first reported a position in FBT in Q4 2018 and has held it in 31 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Fidelity Investments held 2,470 shares of First Trust NYSE Arca Biotechnology Index Fund worth $612K as of Q2 2026.
Fidelity Investments bought 179 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $38.6K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3207 holding.
Fidelity Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and has held it in 31 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.